Company intelligence / Profile preview

Fytexia

Ownership: Private
Employees: ~48
Development stage: Commercial

Overview

Fytexia specializes in the research, development, and commercialization of scientifically supported active nutrients for dietary supplements. Their portfolio includes proprietary polyphenol blends, propolis extracts, peptide-based actives, and enzyme solutions targeting metabolic health, immunity, antioxidant status, bone strength, sleep quality, and food sensitivities. All products are supported by preclinical studies and human clinical trials demonstrating efficacy for specific wellness outcomes. The company operates globally with manufacturing sites in France and Italy.[1][3][5]

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyOtherNeurology
Modalities: Small molecule (nutrients and bioactive compounds)Peptides (peptide-based ingredients)Polyphenols (botanical extracts)Propolis extracts (bee-derived bioactives)Enzyme-based ingredients (via subsidiaries/partners)
Industry: Food & Nutrition

Drug pipeline

2 assets

Sinetrol

Commercial

Indications: Weight management

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborates with global academic institutions/researchers for scientific validation of its productsNo major pharma partnerships disclosed

Beyond the preview

Go deeper on Fytexia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fytexia.

Explore the full profile